Sangamo Therapeutics (SGMOQ) EBITDA (2010 - 2025)
Sangamo Therapeutics (SGMOQ) reported EBITDA of -$37.21 million for Q4 2025, compared with -$24.75 million a year earlier.
Analysis
Sangamo Therapeutics (SGMOQ) EBITDA (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics posted EBITDA of -$117.24 million.
- By year, EBITDA came in at -$98.86 million in FY2024, -$258.91 million in FY2023, -$189.17 million in FY2022 and -$173.9 million in FY2021.
- The Q4 2025 figure ranks as the lowest quarterly EBITDA since Q1 2024.
- Per Business Quant data, the three quarters before Q4 2025 came in at -$34.56 million (Q3 2025), -$16.86 million (Q2 2025) and -$28.61 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Sangamo Therapeutics | 28.02 Mn | -86.09 Mn | - | -37.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -37.21 Mn |
| Sep 30, 2025 | -34.56 Mn |
| Jun 30, 2025 | -16.86 Mn |
| Mar 31, 2025 | -28.61 Mn |
| Dec 31, 2024 | -24.75 Mn |
| Sep 30, 2024 | 11.85 Mn |
| Jun 30, 2024 | -35.84 Mn |
| Mar 31, 2024 | -50.12 Mn |
| Dec 31, 2023 | -60.20 Mn |
| Sep 30, 2023 | -100.92 Mn |
| Jun 30, 2023 | -119.32 Mn |
| Mar 31, 2023 | 21.52 Mn |
| Dec 31, 2022 | -52.05 Mn |
| Sep 30, 2022 | -51.85 Mn |
| Jun 30, 2022 | -42.85 Mn |
| Mar 31, 2022 | -42.43 Mn |
| Dec 31, 2021 | -37.14 Mn |
| Sep 30, 2021 | -45.88 Mn |
| Jun 30, 2021 | -46.46 Mn |
| Mar 31, 2021 | -44.43 Mn |
API Access
Sangamo Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();